An integrated proteo-transcriptomics approach reveals novel drug targets against multidrug resistant Escherichia coli

Infections due to multidrug-resistant (MDR) Escherichia coli are associated with severe morbidity and mortality, worldwide. Microbial drug resistance is a complex phenomenon which is conditioned by an interplay of several genomic, transcriptomic and proteomic factors. Here, we have conducted an inte...

Full description

Saved in:
Bibliographic Details
Main Authors: Manisha Aswal, Nirpendra Singh, Neelja Singhal, Manish Kumar
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2025.1531739/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849722611888553984
author Manisha Aswal
Nirpendra Singh
Neelja Singhal
Manish Kumar
author_facet Manisha Aswal
Nirpendra Singh
Neelja Singhal
Manish Kumar
author_sort Manisha Aswal
collection DOAJ
description Infections due to multidrug-resistant (MDR) Escherichia coli are associated with severe morbidity and mortality, worldwide. Microbial drug resistance is a complex phenomenon which is conditioned by an interplay of several genomic, transcriptomic and proteomic factors. Here, we have conducted an integrated transcriptomics and proteomics analysis of MDR E. coli to identify genes which are differentially expressed at both mRNA and protein levels. Using RNA-Seq and SWATH-LC MS/MS it was discerned that 763 genes/proteins exhibited differential expression. Of these, 52 genes showed concordance in differential expression at both mRNA and protein levels with 41 genes exhibiting overexpression and 11 genes exhibiting under expression. Bioinformatic analysis using GO-terms, COG and KEGG functional annotations revealed that the concordantly overexpressed genes of MDR E. coli were involved primarily in biosynthesis of secondary metabolites, aminoacyl-tRNAs and ribosomes. Protein–protein interaction (PPI) network analysis of the concordantly overexpressed genes revealed 81 PPI networks and 10 hub proteins. The hub proteins (rpsI, aspS, valS, lysS, accC, topA, rpmG, rpsR, lysU, and spmB) were found to be involved in aminoacylation of tRNA and lysyl-tRNA and, translation. Further, it was discerned that three hub proteins - smpB, rpsR, and topA were non homologous to human proteins and were involved in several biological pathways directly and/or indirectly related to antibiotic stress. Also, absence of homology ensures a little cross-reactivity of their inhibitors/drugs with human proteins and undesirable side effects. Thus, these proteins might be explored as novel drug targets against both drug-resistant and -sensitive populations of E. coli.
format Article
id doaj-art-4bbd7150eecc404ca1a688d5b8989dbf
institution DOAJ
issn 1664-302X
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj-art-4bbd7150eecc404ca1a688d5b8989dbf2025-08-20T03:11:17ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-02-011610.3389/fmicb.2025.15317391531739An integrated proteo-transcriptomics approach reveals novel drug targets against multidrug resistant Escherichia coliManisha Aswal0Nirpendra Singh1Neelja Singhal2Manish Kumar3Department of Biophysics, University of Delhi South Campus, New Delhi, IndiaInstitute of Stem Cell Science and Regenerative Medicine, Bengaluru, IndiaDepartment of Biophysics, University of Delhi South Campus, New Delhi, IndiaDepartment of Biophysics, University of Delhi South Campus, New Delhi, IndiaInfections due to multidrug-resistant (MDR) Escherichia coli are associated with severe morbidity and mortality, worldwide. Microbial drug resistance is a complex phenomenon which is conditioned by an interplay of several genomic, transcriptomic and proteomic factors. Here, we have conducted an integrated transcriptomics and proteomics analysis of MDR E. coli to identify genes which are differentially expressed at both mRNA and protein levels. Using RNA-Seq and SWATH-LC MS/MS it was discerned that 763 genes/proteins exhibited differential expression. Of these, 52 genes showed concordance in differential expression at both mRNA and protein levels with 41 genes exhibiting overexpression and 11 genes exhibiting under expression. Bioinformatic analysis using GO-terms, COG and KEGG functional annotations revealed that the concordantly overexpressed genes of MDR E. coli were involved primarily in biosynthesis of secondary metabolites, aminoacyl-tRNAs and ribosomes. Protein–protein interaction (PPI) network analysis of the concordantly overexpressed genes revealed 81 PPI networks and 10 hub proteins. The hub proteins (rpsI, aspS, valS, lysS, accC, topA, rpmG, rpsR, lysU, and spmB) were found to be involved in aminoacylation of tRNA and lysyl-tRNA and, translation. Further, it was discerned that three hub proteins - smpB, rpsR, and topA were non homologous to human proteins and were involved in several biological pathways directly and/or indirectly related to antibiotic stress. Also, absence of homology ensures a little cross-reactivity of their inhibitors/drugs with human proteins and undesirable side effects. Thus, these proteins might be explored as novel drug targets against both drug-resistant and -sensitive populations of E. coli.https://www.frontiersin.org/articles/10.3389/fmicb.2025.1531739/fullRNA-SeqSWATH-LC MS/MSprotein–protein interactionsmultidrug resistancedrug target
spellingShingle Manisha Aswal
Nirpendra Singh
Neelja Singhal
Manish Kumar
An integrated proteo-transcriptomics approach reveals novel drug targets against multidrug resistant Escherichia coli
Frontiers in Microbiology
RNA-Seq
SWATH-LC MS/MS
protein–protein interactions
multidrug resistance
drug target
title An integrated proteo-transcriptomics approach reveals novel drug targets against multidrug resistant Escherichia coli
title_full An integrated proteo-transcriptomics approach reveals novel drug targets against multidrug resistant Escherichia coli
title_fullStr An integrated proteo-transcriptomics approach reveals novel drug targets against multidrug resistant Escherichia coli
title_full_unstemmed An integrated proteo-transcriptomics approach reveals novel drug targets against multidrug resistant Escherichia coli
title_short An integrated proteo-transcriptomics approach reveals novel drug targets against multidrug resistant Escherichia coli
title_sort integrated proteo transcriptomics approach reveals novel drug targets against multidrug resistant escherichia coli
topic RNA-Seq
SWATH-LC MS/MS
protein–protein interactions
multidrug resistance
drug target
url https://www.frontiersin.org/articles/10.3389/fmicb.2025.1531739/full
work_keys_str_mv AT manishaaswal anintegratedproteotranscriptomicsapproachrevealsnoveldrugtargetsagainstmultidrugresistantescherichiacoli
AT nirpendrasingh anintegratedproteotranscriptomicsapproachrevealsnoveldrugtargetsagainstmultidrugresistantescherichiacoli
AT neeljasinghal anintegratedproteotranscriptomicsapproachrevealsnoveldrugtargetsagainstmultidrugresistantescherichiacoli
AT manishkumar anintegratedproteotranscriptomicsapproachrevealsnoveldrugtargetsagainstmultidrugresistantescherichiacoli
AT manishaaswal integratedproteotranscriptomicsapproachrevealsnoveldrugtargetsagainstmultidrugresistantescherichiacoli
AT nirpendrasingh integratedproteotranscriptomicsapproachrevealsnoveldrugtargetsagainstmultidrugresistantescherichiacoli
AT neeljasinghal integratedproteotranscriptomicsapproachrevealsnoveldrugtargetsagainstmultidrugresistantescherichiacoli
AT manishkumar integratedproteotranscriptomicsapproachrevealsnoveldrugtargetsagainstmultidrugresistantescherichiacoli